FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2753206881> ?p ?o ?g. }

• W2753206881 endingPage "2243" @default.
• W2753206881 startingPage "2234" @default.
• W2753206881 abstract "Abstract The aim of this retrospective study was to report long‐term clinical outcomes in patients treated with proton therapy ( PT ) for localized prostate cancer. Between 2001 and 2014, 1375 consecutive patients were treated with PT . Patients were classified into prognostic risk groups based on the National Comprehensive Cancer Network criteria. Freedom from biochemical relapse ( FFBR ), cancer‐specific survival ( CSS ) and incidence of late gastrointestinal ( GI )/genitourinary ( GU ) toxicities were calculated. Multivariate analysis was performed to identify clinical prognostic factors for FFBR and late toxicities. The median follow‐up period was 70 months (range, 4–145 months). In total, 99% of patients received 74 Gy (relative biologic effectiveness [ RBE ]); 56% of patients received neoadjuvant androgen deprivation therapy. For the low‐, intermediate‐, high‐, and very high‐risk groups, 5‐year FFBR was 99% (95% confidence intervals [ CI ], 96–100%), 91% (95% CI , 88–93%), 86% (95% CI , 82–89%), and 66% (95% CI , 53–76%), respectively, and 5‐year CSS was 100% (95% CI , 100–100%), 100% (95% CI , 100–100%) , 99% (95% CI , 97–100%), and 95% (95% CI , 94–98%), respectively. Patient age, T classification, Gleason score, prostate‐specific antigen, and percentage of positive cores were significant prognostic factors for FFBR . Grade 2 or higher GI and GU toxicities were 3.9% and 2.0%. Patient age was a prognostic factor for both late GI and GU toxicities. This study represents the largest cohort of patients treated with PT for localized prostate cancer, with the longest follow‐up to date. Our results demonstrate that the biochemical control of PT is favorable particularly for high‐ and very high‐risk patients with lower late genitourinary toxicity and indicates the necessity of considering patient age in the treatment protocols." @default.
• W2753206881 created "2017-09-15" @default.
• W2753206881 creator A5018944066 @default.
• W2753206881 creator A5019016040 @default.
• W2753206881 creator A5022734887 @default.
• W2753206881 creator A5041084087 @default.
• W2753206881 creator A5045012751 @default.
• W2753206881 creator A5050491832 @default.
• W2753206881 creator A5057618408 @default.
• W2753206881 creator A5063247171 @default.
• W2753206881 creator A5070357229 @default.
• W2753206881 creator A5080516835 @default.
• W2753206881 date "2017-09-06" @default.
• W2753206881 modified "2023-10-05" @default.
• W2753206881 title "Long-term outcomes in patients treated with proton therapy for localized prostate cancer" @default.
• W2753206881 cites W1492653833 @default.
• W2753206881 cites W1815438327 @default.
• W2753206881 cites W1968042369 @default.
• W2753206881 cites W1994364707 @default.
• W2753206881 cites W2004246843 @default.
• W2753206881 cites W2004375292 @default.
• W2753206881 cites W2012514380 @default.
• W2753206881 cites W2014044108 @default.
• W2753206881 cites W2017834862 @default.
• W2753206881 cites W2028855764 @default.
• W2753206881 cites W2040085036 @default.
• W2753206881 cites W2054899405 @default.
• W2753206881 cites W2066225048 @default.
• W2753206881 cites W2093867637 @default.
• W2753206881 cites W2095549404 @default.
• W2753206881 cites W2098733695 @default.
• W2753206881 cites W2101001966 @default.
• W2753206881 cites W2103275355 @default.
• W2753206881 cites W2104822640 @default.
• W2753206881 cites W2104874527 @default.
• W2753206881 cites W2121960517 @default.
• W2753206881 cites W2126763861 @default.
• W2753206881 cites W2127755970 @default.
• W2753206881 cites W2134013455 @default.
• W2753206881 cites W2152182740 @default.
• W2753206881 cites W2155907962 @default.
• W2753206881 cites W2159192512 @default.
• W2753206881 cites W2160406420 @default.
• W2753206881 cites W2182428147 @default.
• W2753206881 cites W2283825277 @default.
• W2753206881 cites W3144729699 @default.
• W2753206881 doi "https://doi.org/10.1002/cam4.1159" @default.
• W2753206881 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5633560" @default.
• W2753206881 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28879658" @default.
• W2753206881 hasPublicationYear "2017" @default.
• W2753206881 type Work @default.
• W2753206881 sameAs 2753206881 @default.
• W2753206881 citedByCount "30" @default.
• W2753206881 countsByYear W27532068812018 @default.
• W2753206881 countsByYear W27532068812019 @default.
• W2753206881 countsByYear W27532068812020 @default.
• W2753206881 countsByYear W27532068812021 @default.
• W2753206881 countsByYear W27532068812022 @default.
• W2753206881 countsByYear W27532068812023 @default.
• W2753206881 crossrefType "journal-article" @default.
• W2753206881 hasAuthorship W2753206881A5018944066 @default.
• W2753206881 hasAuthorship W2753206881A5019016040 @default.
• W2753206881 hasAuthorship W2753206881A5022734887 @default.
• W2753206881 hasAuthorship W2753206881A5041084087 @default.
• W2753206881 hasAuthorship W2753206881A5045012751 @default.
• W2753206881 hasAuthorship W2753206881A5050491832 @default.
• W2753206881 hasAuthorship W2753206881A5057618408 @default.
• W2753206881 hasAuthorship W2753206881A5063247171 @default.
• W2753206881 hasAuthorship W2753206881A5070357229 @default.
• W2753206881 hasAuthorship W2753206881A5080516835 @default.
• W2753206881 hasBestOaLocation W27532068811 @default.
• W2753206881 hasConcept C120665830 @default.
• W2753206881 hasConcept C121332964 @default.
• W2753206881 hasConcept C121608353 @default.
• W2753206881 hasConcept C126322002 @default.
• W2753206881 hasConcept C133507102 @default.
• W2753206881 hasConcept C143998085 @default.
• W2753206881 hasConcept C167135981 @default.
• W2753206881 hasConcept C2776235491 @default.
• W2753206881 hasConcept C2777899217 @default.
• W2753206881 hasConcept C2780192828 @default.
• W2753206881 hasConcept C38180746 @default.
• W2753206881 hasConcept C44249647 @default.
• W2753206881 hasConcept C61511704 @default.
• W2753206881 hasConcept C71924100 @default.
• W2753206881 hasConcept C72563966 @default.
• W2753206881 hasConcept C90924648 @default.
• W2753206881 hasConceptScore W2753206881C120665830 @default.
• W2753206881 hasConceptScore W2753206881C121332964 @default.
• W2753206881 hasConceptScore W2753206881C121608353 @default.
• W2753206881 hasConceptScore W2753206881C126322002 @default.
• W2753206881 hasConceptScore W2753206881C133507102 @default.
• W2753206881 hasConceptScore W2753206881C143998085 @default.
• W2753206881 hasConceptScore W2753206881C167135981 @default.
• W2753206881 hasConceptScore W2753206881C2776235491 @default.
• W2753206881 hasConceptScore W2753206881C2777899217 @default.
• W2753206881 hasConceptScore W2753206881C2780192828 @default.
• W2753206881 hasConceptScore W2753206881C38180746 @default.

• next